强直性脊柱炎临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 强直性脊柱炎（国际通用名 ankylosing spondylitis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖强直等说法。

正在招募的强直性脊柱炎新药试验

• The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

  不适用招募中中国NCT06844643

• Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis

  不适用招募中EgyptNCT06642207

• Clinical Trial Study on the Improved New Method of Acupotomy for AS

  不适用招募中中国NCT07578220

• Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

  不适用招募中中国NCT07509775

• Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia.

  不适用招募中德国NCT07561255

• Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis

  不适用招募中Turkey (Türkiye)NCT07633730

• Exactech Shoulder Post Market Clinical Follow-up Study

  不适用招募中美国加拿大法国意大利NCT05603728

• An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

  III 期招募中加拿大法国德国PolandNCT06668181

• Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

  不适用招募中中国NCT07556224

• Bidirectional Cohort Study of Nanfang Spondyloarthritis

  不适用招募中中国NCT06988813

• Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

  III 期招募中中国NCT07172360

• Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

  IV 期招募中中国NCT06707194